USD 29.53
(-0.37%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 5.27 Billion USD | 0.77% |
2022 | 4.52 Billion USD | 33.37% |
2021 | 3.39 Billion USD | 14.27% |
2020 | 2.97 Billion USD | -23.53% |
2019 | 3.88 Billion USD | 22.09% |
2018 | 3.18 Billion USD | -0.93% |
2017 | 3.21 Billion USD | -5.14% |
2016 | 3.38 Billion USD | -8.41% |
2015 | 3.69 Billion USD | -32.17% |
2014 | 5.45 Billion USD | 10.61% |
2013 | 4.92 Billion USD | 9.98% |
2012 | 4.48 Billion USD | 9.27% |
2011 | 4.1 Billion USD | 7.27% |
2010 | 3.82 Billion USD | 4.77% |
2009 | 3.64 Billion USD | 2.3% |
2008 | 3.56 Billion USD | 8.69% |
2007 | 3.28 Billion USD | 13.29% |
2006 | 2.89 Billion USD | 12.99% |
2005 | 2.56 Billion USD | -7.34% |
2004 | 2.76 Billion USD | 17.75% |
2003 | 2.34 Billion USD | 13.86% |
2002 | 2.06 Billion USD | 6.18% |
2001 | 1.94 Billion USD | -10.42% |
2000 | 2.16 Billion USD | 7.64% |
1999 | 2.01 Billion USD | -9.68% |
1998 | 2.23 Billion USD | 3.96% |
1997 | 2.14 Billion USD | 17.27% |
1996 | 1.83 Billion USD | 3.68% |
1995 | 1.76 Billion USD | -35.25% |
1994 | 2.72 Billion USD | -21.6% |
1993 | 3.47 Billion USD | 31.56% |
1992 | 2.64 Billion USD | 1.3% |
1991 | 2.6 Billion USD | -10.77% |
1990 | 2.92 Billion USD | 34.19% |
1989 | 2.17 Billion USD | 4.56% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.04 Billion USD | 17.52% |
2024 Q1 | 1.01 Billion USD | -8.22% |
2023 Q2 | 1.12 Billion USD | -2.76% |
2023 Q4 | 1.1 Billion USD | -5.22% |
2023 Q3 | 1.16 Billion USD | 3.45% |
2023 Q1 | 1.16 Billion USD | 7.2% |
2023 FY | 4.56 Billion USD | 0.77% |
2022 Q1 | 1.2 Billion USD | 17.5% |
2022 Q2 | 1.11 Billion USD | -7.4% |
2022 Q4 | 1.08 Billion USD | -5.17% |
2022 FY | 4.52 Billion USD | 33.37% |
2022 Q3 | 1.14 Billion USD | 2.61% |
2021 Q4 | 1.02 Billion USD | 26.61% |
2021 Q3 | 808 Million USD | -0.49% |
2021 Q2 | 812 Million USD | 7.55% |
2021 FY | 3.39 Billion USD | 14.27% |
2021 Q1 | 755 Million USD | -3.82% |
2020 Q3 | 724 Million USD | 2.4% |
2020 Q4 | 785 Million USD | 8.43% |
2020 FY | 2.97 Billion USD | -23.53% |
2020 Q2 | 707 Million USD | -6.23% |
2020 Q1 | 754 Million USD | -52.19% |
2019 Q3 | 771 Million USD | -4.1% |
2019 Q4 | 1.57 Billion USD | 104.54% |
2019 Q2 | 804 Million USD | 15.52% |
2019 Q1 | 696 Million USD | -12.34% |
2019 FY | 3.88 Billion USD | 22.09% |
2018 Q3 | 851 Million USD | -0.47% |
2018 FY | 3.18 Billion USD | -0.93% |
2018 Q4 | 794 Million USD | -6.7% |
2018 Q2 | 855 Million USD | 12.2% |
2018 Q1 | 762 Million USD | -13.31% |
2017 Q2 | 791 Million USD | 13.32% |
2017 Q3 | 836 Million USD | 5.69% |
2017 FY | 3.21 Billion USD | -5.14% |
2017 Q4 | 879 Million USD | 5.14% |
2017 Q1 | 698 Million USD | -14.88% |
2016 Q4 | 820 Million USD | -7.34% |
2016 FY | 3.38 Billion USD | -8.41% |
2016 Q1 | 777 Million USD | -13.09% |
2016 Q2 | 904 Million USD | 16.34% |
2016 Q3 | 885 Million USD | -2.1% |
2015 Q3 | 942 Million USD | -36.57% |
2015 FY | 3.69 Billion USD | -32.17% |
2015 Q1 | 1.31 Billion USD | -7.78% |
2015 Q2 | 1.48 Billion USD | 12.93% |
2015 Q4 | 894 Million USD | -5.1% |
2014 Q3 | 1.49 Billion USD | 13.0% |
2014 FY | 5.45 Billion USD | 10.61% |
2014 Q1 | 1.23 Billion USD | -17.85% |
2014 Q4 | 1.42 Billion USD | -4.62% |
2014 Q2 | 1.32 Billion USD | 7.3% |
2013 Q4 | 1.5 Billion USD | 17.82% |
2013 FY | 4.92 Billion USD | 9.98% |
2013 Q1 | 1.04 Billion USD | -21.79% |
2013 Q2 | 1.11 Billion USD | 6.72% |
2013 Q3 | 1.27 Billion USD | 14.67% |
2012 FY | 4.48 Billion USD | 9.27% |
2012 Q1 | 1.02 Billion USD | -10.44% |
2012 Q2 | 1.09 Billion USD | 7.25% |
2012 Q3 | 1.03 Billion USD | -5.66% |
2012 Q4 | 1.33 Billion USD | 28.85% |
2011 FY | 4.1 Billion USD | 7.27% |
2011 Q1 | 930 Million USD | -15.07% |
2011 Q2 | 1 Billion USD | 7.96% |
2011 Q3 | 1.02 Billion USD | 2.19% |
2011 Q4 | 1.14 Billion USD | 11.11% |
2010 Q2 | 940 Million USD | 3.3% |
2010 Q4 | 1.09 Billion USD | 24.15% |
2010 Q1 | 910 Million USD | -11.99% |
2010 FY | 3.82 Billion USD | 4.77% |
2010 Q3 | 882 Million USD | -6.17% |
2009 FY | 3.64 Billion USD | 2.3% |
2009 Q3 | 900 Million USD | 1.01% |
2009 Q2 | 891 Million USD | 8.26% |
2009 Q1 | 823 Million USD | -8.56% |
2009 Q4 | 1.03 Billion USD | 14.89% |
2008 FY | 3.56 Billion USD | 8.69% |
2008 Q2 | 925 Million USD | 11.45% |
2008 Q4 | 900 Million USD | -1.21% |
2008 Q3 | 911 Million USD | -1.51% |
2008 Q1 | 830 Million USD | -5.14% |
2007 FY | 3.28 Billion USD | 13.29% |
2007 Q4 | 875 Million USD | 1.04% |
2007 Q3 | 866 Million USD | 8.52% |
2007 Q2 | 798 Million USD | 7.55% |
2007 Q1 | 742 Million USD | -6.43% |
2006 Q2 | 728 Million USD | 9.64% |
2006 Q1 | 664 Million USD | 1.68% |
2006 FY | 2.89 Billion USD | 12.99% |
2006 Q4 | 793 Million USD | 11.53% |
2006 Q3 | 711 Million USD | -2.34% |
2005 Q3 | 624 Million USD | -6.87% |
2005 FY | 2.56 Billion USD | -7.34% |
2005 Q2 | 670 Million USD | 4.69% |
2005 Q1 | 640 Million USD | -30.21% |
2005 Q4 | 653 Million USD | 4.65% |
2004 Q3 | 586 Million USD | -11.35% |
2004 Q1 | 603 Million USD | -3.05% |
2004 Q4 | 917 Million USD | 56.48% |
2004 FY | 2.76 Billion USD | 17.75% |
2004 Q2 | 661 Million USD | 9.62% |
2003 Q2 | 603 Million USD | 9.84% |
2003 Q4 | 622 Million USD | 8.17% |
2003 Q3 | 575 Million USD | -4.64% |
2003 Q1 | 549 Million USD | 3.98% |
2003 FY | 2.34 Billion USD | 13.86% |
2002 Q1 | 515 Million USD | -4.63% |
2002 Q4 | 528 Million USD | 4.14% |
2002 Q2 | 513 Million USD | -0.39% |
2002 Q3 | 507 Million USD | -1.17% |
2002 FY | 2.06 Billion USD | 6.18% |
2001 Q3 | 469 Million USD | -1.47% |
2001 Q2 | 476 Million USD | 3.93% |
2001 FY | 1.94 Billion USD | -10.42% |
2001 Q1 | 458 Million USD | -25.65% |
2001 Q4 | 540 Million USD | 15.14% |
2000 Q2 | 515 Million USD | 4.04% |
2000 Q4 | 616 Million USD | 13.44% |
2000 FY | 2.16 Billion USD | 7.64% |
2000 Q3 | 543 Million USD | 5.44% |
2000 Q1 | 495 Million USD | -8.84% |
1999 FY | 2.01 Billion USD | -9.68% |
1999 Q1 | 568 Million USD | -5.49% |
1999 Q2 | 511 Million USD | -10.04% |
1999 Q3 | 463 Million USD | -9.39% |
1999 Q4 | 543 Million USD | 17.28% |
1998 Q1 | 500 Million USD | -12.28% |
1998 FY | 2.23 Billion USD | 3.96% |
1998 Q4 | 601 Million USD | 6.18% |
1998 Q2 | 564 Million USD | 12.8% |
1998 Q3 | 566 Million USD | 0.35% |
1997 Q4 | 570 Million USD | 9.83% |
1997 FY | 2.14 Billion USD | 17.27% |
1997 Q1 | 522 Million USD | 5.45% |
1997 Q2 | 535 Million USD | 2.49% |
1997 Q3 | 519 Million USD | -2.99% |
1996 Q4 | 495 Million USD | 12.5% |
1996 Q3 | 440 Million USD | -2.87% |
1996 Q2 | 453 Million USD | 2.49% |
1996 Q1 | 442 Million USD | 326.67% |
1996 FY | 1.83 Billion USD | 3.68% |
1995 Q2 | 656 Million USD | 3.96% |
1995 Q1 | 631 Million USD | -12.48% |
1995 FY | 1.76 Billion USD | -35.25% |
1995 Q4 | -195 Million USD | -128.97% |
1995 Q3 | 673 Million USD | 2.59% |
1994 Q4 | 721 Million USD | 4.19% |
1994 Q2 | 672 Million USD | 4.84% |
1994 Q3 | 692 Million USD | 2.98% |
1994 FY | 2.72 Billion USD | -21.6% |
1994 Q1 | 641 Million USD | -54.41% |
1993 Q3 | 697 Million USD | -3.73% |
1993 Q2 | 724 Million USD | 11.38% |
1993 Q4 | 1.4 Billion USD | 101.72% |
1993 FY | 3.47 Billion USD | 31.56% |
1993 Q1 | 650 Million USD | -9.97% |
1992 Q4 | 722 Million USD | 12.11% |
1992 Q1 | 681 Million USD | 0.15% |
1992 FY | 2.64 Billion USD | 1.3% |
1992 Q3 | 644 Million USD | 0.16% |
1992 Q2 | 643 Million USD | -5.58% |
1991 Q1 | 636 Million USD | 2.09% |
1991 Q2 | 650 Million USD | 2.2% |
1991 Q3 | 643 Million USD | -1.08% |
1991 Q4 | 680 Million USD | 5.75% |
1991 FY | 2.6 Billion USD | -10.77% |
1990 Q4 | 623 Million USD | 7.04% |
1990 Q3 | 582 Million USD | 1.04% |
1990 Q1 | 1.14 Billion USD | 123.24% |
1990 Q2 | 576 Million USD | -49.61% |
1990 FY | 2.92 Billion USD | 34.19% |
1989 Q1 | 558 Million USD | 109.12% |
1989 Q3 | 547 Million USD | -2.67% |
1989 Q2 | 562 Million USD | 0.72% |
1989 Q4 | 512 Million USD | -6.4% |
1989 FY | 2.17 Billion USD | 4.56% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Phreesia, Inc. | 369.84 Million USD | -1325.477% |
Accuray Incorporated | 142.61 Million USD | -3596.614% |
Align Technology, Inc. | 2.07 Billion USD | -153.849% |
Elevance Health Inc. | 36.23 Billion USD | 85.451% |
AxoGen, Inc. | 149.33 Million USD | -3430.294% |
Boston Scientific Corporation | 7.5 Billion USD | 29.763% |
CVS Health Corporation | 40.68 Billion USD | 87.043% |
Cardinal Health, Inc. | 5 Billion USD | -5.44% |
Centene Corporation | 138.33 Billion USD | 96.189% |
DaVita Inc. | 1.47 Billion USD | -257.67% |
HCA Healthcare, Inc. | 45.43 Billion USD | 88.398% |
Hologic, Inc. | 1.26 Billion USD | -315.904% |
Humana Inc. | 102.36 Billion USD | 94.85% |
IDEXX Laboratories, Inc. | 1.09 Billion USD | -382.412% |
Laboratory Corporation of America Holdings | 2.02 Billion USD | -160.809% |
Masimo Corporation | 867 Million USD | -508.074% |
McKesson Corporation | 8.67 Billion USD | 39.228% |
Patterson Companies, Inc. | 1.12 Billion USD | -367.659% |
Quest Diagnostics Incorporated | 1.61 Billion USD | -227.453% |
ResMed Inc. | 1.36 Billion USD | -285.275% |
Henry Schein, Inc. | 2.93 Billion USD | -79.503% |
Teladoc Health, Inc. | 2.09 Billion USD | -152.136% |
Universal Health Services, Inc. | 9.2 Billion USD | 42.748% |
Veeva Systems Inc. | 1.25 Billion USD | -319.395% |
Becton, Dickinson and Company | 6.71 Billion USD | 21.454% |
Intuitive Surgical, Inc. | 2.96 Billion USD | -77.946% |
Danaher Corporation | 8.75 Billion USD | 39.783% |
Stryker Corporation | 9.2 Billion USD | 42.752% |
Medtronic plc | 16.12 Billion USD | 67.314% |